GlenmarkPharma
bd_0519087b6c0a3dc4 · schema v1 · pii pii-v1
Full breach record for GlenmarkPharma →Threat-actor claim — not a regulatory filing
This row is a claim by the ransomware group INC Ransom on its public extortion blog. It has not been validated by the victim or any regulator. Treat attribution and counts as the threat actor's assertion until a regulatory filing or victim disclosure corroborates them.
Source: Ransomware.live
Post text · scraped from the leak site
Glenmark Pharmaceuticals, founded in 1977 and headquartered in Mumbai, India, is a global pharmaceutical company that develops, manufactures, and markets pharmaceutical products. The company operates in over 25 countries across North America, South America, Europe, Asia, Africa, and the Middle East, with a strong focus on research and development of innovative medications. Glenmark specializes in various therapeutic areas and maintains a diverse portfolio of pharmaceutical products serving both business and consumer markets worldwide. Rajeev Sharma Senior Vice President and Chief Financial Officer - North America Laura Lester Senior Vice President & General Counsel - North America Jim Brown Senior Vice President Firas B Abulaban Senior Vice President and Corporate Quality Head of North America Bradley Nowels Vice President Institutional Sales – North America Vishal Arora Vice President of Business Development and Licensing Michael Pope Executive Director and Site Head – Monroe, NC Adam Subervi Chief Compliance Officer Fabio Moreno Executive Director and Head of the OTC Business Kathleen (Kathy) McKenna Senior Director – Human Resources INVESTORS Company Secretary & Compliance Officer ComplianceOfficer@glenmarkpharma.com Tel No.: +91 22 4018 9999 Fax No.: +91 22 4018 9986 REGISTRAR AND SHARE TRANSFER AGENTS KFIN Technologies Limited Selenium Building, Tower-B, Plot No 31 & 32,Financial District, Nanakramguda, Serilingampally, Hyderabad, Rangareddy, Telangana, India – 500 032. Email ID: einward.ris@kfintech.com Toll Free/ Phone Number : 1800 309 4001 WhatsApp Number : (91) 910 009 4099 KFINTECH Corporate Website: www.kfintech.com RTA Website: https://ris.kfintech.com Investor Support Centre (DIY Link) https://ris.kfintech.com/clientservices/isc BUSINESS DEVELOPMENT For queries related to collaboration and partnership, please email
Source provenance
- Source URL
- https://www.ransomware.live/id/Z2xlbm1hcmtwaGFybWEuY29tQGluY3JhbnNvbQ==
DisclosureLens links to the originating regulator URL — full filing bodies are not redistributed from public surfaces (§4.5).
- Filed at
- Mar 25, 2026
- Raw hash
- b18941d9f9d822a600a8c1c3e60741ffecb52bf5c6276ecc5ff24b00afa79baf
Reporting entity
- Name
- incransomnorm: inc_ransom
Victim entity
- Name
- GlenmarkPharmanorm: glenmarkpharma
- Domain
- glenmarkpharma.com
- Industry
- Healthcare
What this source establishes
- Source ceiling
- A leak-site claim can't tell us: discovery date · materiality · notification · affected count · confirmed data types · compliance clock. These stay blank until a regulatory filing or victim disclosure lands.
- Attack vector
- Ransomware· inc_ransom
- Threat actor
- Inc RansomExternalFinancial
Compliance
- Compliance flags
- — (clock not assessable for this source)
Extraction provenance
- Status
- No extraction artifact recorded for this disclosure.